Advertisement

Current Diabetes Reports

, 17:115 | Cite as

Screening and Treatment for Early-Onset Gestational Diabetes Mellitus: a Systematic Review and Meta-analysis

  • Jincy Immanuel
  • David Simmons
Diabetes and Pregnancy (M-F Hivert, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Diabetes and Pregnancy

Abstract

Purpose of Review

We conducted a systematic review to evaluate the current evidence for screening and treatment for early-onset gestational diabetes mellitus (GDM)

Recent Findings

Many of the women with early GDM in the first trimester do not have evidence of hyperglycemia at 24–28 weeks’ gestation.

Summary

A high proportion (15–70%) of women with GDM can be detected early in pregnancy depending on the setting, criteria used and screening strategy. However, there remains no good evidence for any of the diagnostic criteria for early-onset GDM. In a meta-analysis of 13 cohort studies, perinatal mortality (relative risk (RR) 3.58 [1.91, 6.71]), neonatal hypoglycemia (RR 1.61 [1.02, 2.55]), and insulin use (RR 1.71 [1.45, 2.03]) were greater among early-onset GDM women compared to late-onset GDM women, despite treatment. Considering the high likelihood of benefit from treatment, there is an urgent need for randomized controlled trials that investigate any benefits and possible harms of treatment of early-onset GDM.

Keywords

Gestational diabetes mellitus Early-onset GDM Booking gestational diabetes Systematic review Meta-analysis 

Notes

Compliance with Ethical Standards

Conflict of Interest

Jincy Immanuel is supported by a post-graduate research scholarship from Western Sydney University. David Simmons declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Supplementary material

11892_2017_943_MOESM1_ESM.docx (95 kb)
Supplementary Table 1 (DOCX 94 kb)
11892_2017_943_MOESM2_ESM.docx (26 kb)
Supplementary Table 2 (DOCX 25 kb)
11892_2017_943_MOESM3_ESM.docx (18 kb)
Supplementary Table 3 (DOCX 17 kb)
11892_2017_943_MOESM4_ESM.docx (93 kb)
Supplementary Table 4 (DOCX 93 kb)
11892_2017_943_MOESM5_ESM.docx (89 kb)
Supplementary Table 5 (DOCX 88 kb)
11892_2017_943_MOESM6_ESM.docx (18 kb)
Supplementary Table 6 (DOCX 17 kb)
11892_2017_943_MOESM7_ESM.docx (18 kb)
Supplementary Table 7 (DOCX 17 kb)
11892_2017_943_MOESM8_ESM.docx (14 kb)
Supplementary Table 8 (DOCX 14 kb)
11892_2017_943_MOESM9_ESM.docx (83 kb)
Supplementary Table 9 (DOCX 82.9 kb)
11892_2017_943_MOESM10_ESM.docx (93 kb)
Supplementary Table 10 (DOCX 93 kb)
11892_2017_943_MOESM11_ESM.docx (94 kb)
Supplementary Table 11 (DOCX 94 kb)
11892_2017_943_MOESM12_ESM.docx (78 kb)
Supplementary Figure 1 (DOCX 78 kb)

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Simmons D. Epidemiologic context of diabetes in pregnancy. In: McCance D, Maresh M, Sacks DA, editors. A practical manual of diabetes in pregnancy. London: Blackwell Publishing; 2010.Google Scholar
  2. 2.
    •• World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy, WHO/NMH/MND/13.2. Geneva: World health Organization. 2013. Available from: http://apps.who.int/iris/bitstream/10665/85975/1/WHO_NMH_MND_13.2_eng.pdf. Accessed November 10, 2016. WHO recommendations for clinicians to detect hyperglycemia in pregnancy.
  3. 3.
    •• HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002. The landmark study that demonstrated the association of lesser degrees of hyperglycemia and adverse pregnancy outcomes. CrossRefGoogle Scholar
  4. 4.
    •• Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773–9. A meta-analysis compiling evidences for increased risk of type 2 diabetes among women with gestational diabetes. CrossRefPubMedGoogle Scholar
  5. 5.
    • Yessoufou A, Moutairou K. Maternal diabetes in pregnancy: early and long-term outcomes on the offspring and the concept of “metabolic memory”. Exp Diabetes Res. 2011. Doi: https://doi.org/10.1155/2011/218598. An article discussing the impact of maternal hyperglycemia on offspring’s life.
  6. 6.
    •• Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477–86. The Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) trial that showed the benefits of treating gestational diabetes in reducing the rate of serious perinatal outcomes. CrossRefPubMedGoogle Scholar
  7. 7.
    •• Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361(14):1339–48. A randomised controlled trial that showed the benefit of treating women with mild carbohydrate intolerence during pregnancy. CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    •• Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–82. The recommendations by the IADPSG Consensus Panel to guide clinicians to detect hyperglycemic disorders in pregnancy. CrossRefPubMedGoogle Scholar
  9. 9.
    •• McIntyre HD, Sacks DA, Barbour LA, Feig DS, Catalano PM, Damm P, et al. Issues with the diagnosis and classification of hyperglycemia in early pregnancy. Diabetes Care. 2015;39(1):53–4. An important article from the IADPSG group discussing the issues with diagnosis of hyperglycemia in early pregnancy. CrossRefPubMedGoogle Scholar
  10. 10.
    •• Zhu WW, Yang HX, Wei YM, Yan J, Wang ZL, Li XL, et al. Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in China. Diabetes Care. 2013;36(3):586–90. An important study that evaluates fasting plasma glucose values at booking for GDM diagnosis. CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Simmons D, Devers MC, Wolmarans L, Johnson E. Difficulties in the use of risk factors to screen for gestational diabetes mellitus. Diabetes Care. 2009;32(1):e8.CrossRefPubMedGoogle Scholar
  12. 12.
    Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.CrossRefPubMedGoogle Scholar
  13. 13.
    Wells GAS, O’Connell BD, Peterson J, Welch V, Losos M, Tugwell P. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed November 10, 2016.
  14. 14.
    Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401–6.CrossRefPubMedGoogle Scholar
  16. 16.
    World Health Organization. Trends in maternal mortality: 1990 to 2010. Tech. Rep., WHO, UNICEF, UNFPA and The World Bank estimates. Geneva, Switzerland, 2012.Google Scholar
  17. 17.
    • Yeral MI, Ozgu-Erdinc AS, Uygur D, Seckin KD, Karsli MF, Danisman AN. Prediction of gestational diabetes mellitus in the first trimester, comparison of fasting plasma glucose, two-step and one-step methods: a prospective randomized controlled trial. Endocrine. 2014;46(3):512–8. A study that shows 75 g OGTT as the best method for GDM screening in the first trimester. CrossRefPubMedGoogle Scholar
  18. 18.
    Osmundson SS, Norton ME, El-Sayed YY, Carter S, Faig JC, Kitzmiller JL. Early screening and treatment of women with prediabetes: a randomized controlled trial. Am J Perinatol. 2016;33(2):172–9.PubMedGoogle Scholar
  19. 19.
    •• Hughes RC, Moore MP, Gullam JE, Mohamed K, Rowan J. An early pregnancy HbA1c >/=5.9% (41 mmol/mol) is optimal for detecting diabetes and identifies women at increased risk of adverse pregnancy outcomes. Diabetes Care. 2014;37(11):2953–9. A large cohort study demonstrating the potential utility of HbA1c in early pregnancy. CrossRefPubMedGoogle Scholar
  20. 20.
    • Mañé L, Flores-Le Roux JA, Benaiges D, Rodríguez M, Marcelo I, Chillarón JJ, et al. Role of first-trimester HbA1c as a predictor of adverse obstetric outcomes in a multiethnic cohort. J Clin Endocrinol Metab. 2017;102(2):390–7. A prospective study showing the utility of HbA1c in ealry pregnancy. PubMedGoogle Scholar
  21. 21.
    • Sweeting AN, Ross GP, Hyett J, Molyneaux L, Tan K, Constantino M, et al. Baseline HbA1c to identify high-risk gestational diabetes: utility in early vs standard gestational diabetes. J Clin Endocrinol Metab. 2017;102(1):150–6. A retrospective cohort study demonstrating the limited utility of HbA1c for early GDM among high-risk women. PubMedGoogle Scholar
  22. 22.
    Balaji V, Madhuri BS, Ashalatha S, Sheela S, Suresh S, Seshiah V. A1C in gestational diabetes mellitus in Asian Indian women. Diabetes Care. 2007;30(7):1865–7.CrossRefPubMedGoogle Scholar
  23. 23.
    Osmundson SS, Zhao BS, Kunz L, Wang E, Popat R, Nimbal VC, et al. First trimester hemoglobin A1c prediction of gestational diabetes. Am J Perinatol. 2016;33(10):977–82.CrossRefPubMedGoogle Scholar
  24. 24.
    Amylidi S, Mosimann B, Stettler C, Fiedler GM, Surbek D, Raio L. First-trimester glycosylated hemoglobin in women at high risk for gestational diabetes. Acta Obstet Gynecol Scand. 2016;95(1):93–7.CrossRefPubMedGoogle Scholar
  25. 25.
    • Maegawa Y, Sugiyama T, Kusaka H, Mitao M, Toyoda N. Screening tests for gestational diabetes in Japan in the 1st and 2nd trimester of pregnancy. Diabetes Res Clin Pract. 2003;62(1):47–53. A study that indicates the higher prevalence of GDM in the first trimester. CrossRefPubMedGoogle Scholar
  26. 26.
    • Harreiter J, Simmons D, Desoye G, Corcoy R, Adelantado JM, Devlieger R, et al. IADPSG and WHO 2013 gestational diabetes mellitus criteria identify obese women with marked insulin resistance in early pregnancy. Diabetes Care. 2016;39(7):e90–2. A study that demonstrates the potential utility of IADPSG/WHO 2013 criteria in early pregnancy to identify high-risk women with metabolic disturbances. CrossRefPubMedGoogle Scholar
  27. 27.
    Dashora U, Dashora V, Kennedy L. Two-hour 75-g oral glucose tolerance test early in pregnancy detects most cases of gestational diabetes. Diabetes Care. 2002;25(4):803.CrossRefPubMedGoogle Scholar
  28. 28.
    Gandhi P, Farrell T. Gestational diabetes mellitus (GDM) screening in morbidly obese pregnant women. Eur J Obstet Gynecol Reprod Biol. 2011;159(2):329–32.CrossRefPubMedGoogle Scholar
  29. 29.
    •• Riskin-Mashiah S, Younes G, Damti A, Auslender R. First-trimester fasting hyperglycemia and adverse pregnancy outcomes. Diabetes Care. 2009;32(9):1639–43. An important study that demonstrates the association of mild hyperglycemia in early pregnancy and increased risk of adverse pregnancy outcomes. CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Riskin-Mashiah S, Damti A, Younes G, Auslender R. First trimester fasting hyperglycemia as a predictor for the development of gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol. 2010;152(2):163–7.CrossRefPubMedGoogle Scholar
  31. 31.
    •• Corrado F, D’Anna R, Cannata ML, Interdonato ML, Pintaudi B, Di Benedetto A. Correspondence between first-trimester fasting glycaemia, and oral glucose tolerance test in gestational diabetes diagnosis. Diabetes Metab. 2012;38(5):458–61. A study that evaluates first trimester fasting plasma glucose values for GDM diagnosis. CrossRefPubMedGoogle Scholar
  32. 32.
    Bhattacharya SM. Fasting or two-hour postprandial plasma glucose levels in early months of pregnancy as screening tools for gestational diabetes mellitus developing in later months of pregnancy. J Obstet Gynaecol Res. 2004;30(4):333–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Agarwal MM, Dhatt GS, Punnose J, Zayed R. Gestational diabetes: fasting and postprandial glucose as first prenatal screening tests in a high-risk population. J Reprod Med. 2007;52(4):299–305.PubMedGoogle Scholar
  34. 34.
    Sacks DA, Chen W, Wolde-Tsadik G, Buchanan TA. Fasting plasma glucose test at the first prenatal visit as a screen for gestational diabetes. Obstet Gynecol. 2003;101(6):1197–203.PubMedGoogle Scholar
  35. 35.
    Meek CL, Murphy HR, Simmons D. Random plasma glucose in early pregnancy is a better predictor of gestational diabetes diagnosis than maternal obesity. Diabetologia. 2016;59(3):445–52.CrossRefPubMedGoogle Scholar
  36. 36.
    Neelakandan R, Sethu PS. Early universal screening for gestational diabetes mellitus. J Clin Diagn Res. 2014;8(4):Oc12–4.PubMedPubMedCentralGoogle Scholar
  37. 37.
    Murgia C, Berria R, Minerba L, Malloci B, Daniele C, Zedda P, et al. Gestational diabetes mellitus in Sardinia: results from an early, universal screening procedure. Diabetes Care. 2006;29(7):1713–4.CrossRefPubMedGoogle Scholar
  38. 38.
    Bartha JL, Martinez-Del-Fresno P, Comino-Delgado R. Early diagnosis of gestational diabetes mellitus and prevention of diabetes-related complications. Eur J Obstet Gynecol Reprod Biol. 2003;109(1):41–4.CrossRefPubMedGoogle Scholar
  39. 39.
    Horie I, Kawasaki E, Sakanaka A, Takashima M, Maeyama M, Ando T, et al. Efficacy of nutrition therapy for glucose intolerance in Japanese women diagnosed with gestational diabetes based on IADPSG criteria during early gestation. Diabetes Res Clin Pract. 2015;107(3):400–6.CrossRefPubMedGoogle Scholar
  40. 40.
    Barahona MJ, Sucunza N, García‐Patterson A, Hernández M, Adelantado JM, Ginovart G, et al. Period of gestational diabetes mellitus diagnosis and maternal and fetal morbidity. Acta Obstet Gynecol Scand. 2005;84(7):622–7.CrossRefPubMedGoogle Scholar
  41. 41.
    • Bartha JL, Martinez-Del-Fresno P, Comino-Delgado R. Gestational diabetes mellitus diagnosed during early pregnancy. Am J Obstet Gynecol. 2000;182(2):346–50. The first study that demonstrated women with early GDM as a high-risk subgroup. CrossRefPubMedGoogle Scholar
  42. 42.
    Berkowitz GS, Roman SH, Lapinski RH, Alvarez M. Maternal characteristics, neonatal outcome, and the time of diagnosis of gestational diabetes. Am J Obstet Gynecol. 1992;167(4):976–82.CrossRefPubMedGoogle Scholar
  43. 43.
    Boriboonhirunsarn D, Kasempipatchai V. Incidence of large for gestational age infants when gestational diabetes mellitus is diagnosed early and late in pregnancy. J Obstet Gynaecol Res. 2016;42(3):273–8.CrossRefPubMedGoogle Scholar
  44. 44.
    De Muylder X. Perinatal complications of gestational diabetes: the influence of the timing of the diagnosis. Eur J Obstet Gynecol Reprod Biol. 1984;18(1–2):35–42.CrossRefPubMedGoogle Scholar
  45. 45.
    Easmin S, Chowdhury TA, Islam MR, Beg A, Jahan MK, Latif T, et al. Obstetric outcome in early and late onset gestational diabetes mellitus. Mymensingh Med J. 2015;24(3):450–6.PubMedGoogle Scholar
  46. 46.
    Gupta S, Dolin C, Jadhav A, Chervenak J, Timor-Tritsch I, Monteagudo A. Obstetrical outcomes in patients with early onset gestational diabetes. J Matern Fetal Neonatal Med. 2016;29(1):27–31.CrossRefPubMedGoogle Scholar
  47. 47.
    Hawkins JS, Lo JY, Casey BM, McIntire DD, Leveno KJ. Diet-treated gestational diabetes mellitus: comparison of early vs routine diagnosis. Am J Obstet Gynecol. 2008;198(3):287.e281–6.Google Scholar
  48. 48.
    • Most OL, Kim JH, Arslan AA, Klauser C. Maternal and neonatal outcomes in early glucose tolerance testing in an obstetric population in New York city. J Perinat Med. 2009;37(2):114–7. A study that demonstrates the greater severity of GDM in the early-onset subgroup. CrossRefPubMedGoogle Scholar
  49. 49.
    Rowan JA, Budden A, Ivanova V, Hughes RC, Sadler LC. Women with an HbA1c of 41-49 mmol/mol (5.9-6.6%): a higher risk subgroup that may benefit from early pregnancy intervention. Diabet Med. 2016;33(1):25–31.CrossRefPubMedGoogle Scholar
  50. 50.
    • Seshiah V, Cynthia A, Balaji V, Balaji MS, Ashalata S, Sheela R, et al. Detection and care of women with gestational diabetes mellitus from early weeks of pregnancy results in birth weight of newborn babies appropriate for gestational age. Diabetes Res Clin Pract. 2008;80(2):199–202. A study showing the benefit of early treatment of GDM. CrossRefPubMedGoogle Scholar
  51. 51.
    Svare JA, Hansen BB, Molsted-Pedersen L. Perinatal complications in women with gestational diabetes mellitus: significance of a diagnosis early in pregnancy. Obstet Gynecol Surv. 2002;57:330–2.CrossRefGoogle Scholar
  52. 52.
    • Sweeting AN, Ross GP, Hyett J, Molyneaux L, Constantino M, Harding AJ, et al. Gestational diabetes mellitus in early pregnancy: evidence for poor pregnancy outcomes despite treatment. Diabetes Care. 2016;39(1):75–81. A retrospective study that demonstrates women with early GDM as a high-risk subgroup with poorer pregnancy outcomes. CrossRefPubMedGoogle Scholar
  53. 53.
    Murgia C, Orrù M, Portoghese E, Garau N, Zedda P, Berria R, et al. Autoimmunity in gestational diabetes mellitus in Sardinia: a preliminary case-control report. Reprod Biol Endocrinol. 2008;6(0):24.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Stoffel M, Bell KL, Blackburn CL, Powell KL, Seo TS, Takeda J, et al. Identification of glucokinase mutations in subjects with gestational diabetes mellitus. Diabetes. 1993;42(6):937–40.CrossRefPubMedGoogle Scholar
  55. 55.
    Mills JL, Jovanovic L, Knopp R, Aarons J, Conley M, Park E, et al. Physiological reduction in fasting plasma glucose concentration in the first trimester of normal pregnancy: the diabetes in early pregnancy study. Metabolism. 1998;47(9):1140–4.CrossRefPubMedGoogle Scholar
  56. 56.
    World Health Organization. Worldwide prevalence of anaemia 1993–2005: WHO global database on anaemia. Geneva: World Health Organization; 2008.Google Scholar
  57. 57.
    World Health Organization. Iron deficiency anaemia: assessment, prevention and control: a guide for programme managers. Geneva: World Health Organization; 2001.Google Scholar
  58. 58.
    Church D, Simmons D. More evidence of the problems of using HbA1c for diagnosing diabetes? The known knowns, the known unknowns and the unknown unknowns. J Intern Med. 2014;276(2):171–3.CrossRefPubMedGoogle Scholar
  59. 59.
    Simmons D, Hlaing T. Interpretation of HbA1c: association with mean cell volume and haemoglobin concentration. Diabet Med. 2014;31(11):1387–92.CrossRefPubMedGoogle Scholar
  60. 60.
    Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992;35(7):595–601.CrossRefPubMedGoogle Scholar
  61. 61.
    Langer O, Levy J, Brustman L, Anyaegbunam A, Merkatz R, Divon M. Glycemic control in gestational diabetes mellitus-how tight is tight enough: small for gestational age versus large for gestational age? Am J Obstet Gynecol. 1989;161(3):646–53.CrossRefPubMedGoogle Scholar
  62. 62.
    Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet. 1998;19(3):268–70.CrossRefPubMedGoogle Scholar
  63. 63.
    Catalano PM, Mele L, Landon MB, Ramin SM, Reddy UM, Casey B, et al. Inadequate weight gain in overweight and obese pregnant women: what is the effect on fetal growth? Am J Obstet Gynecol. 2014;211(2):137.e131–7.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.School of MedicineWestern Sydney UniversityCampbelltownAustralia

Personalised recommendations